Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving virus or bacteriophage
Patent
1996-12-31
1999-01-12
Myers, Carla J.
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving virus or bacteriophage
435 6, 435 71, 435 405, 435 4051, 435 912, 536 2431, 536 2432, 536 2433, 935 8, 935 9, 935 78, C12Q 168, C07H 2104, G01N 3353
Patent
active
058586490
ABSTRACT:
Fetal cells may be obtained from amniocentesis, chorionic villus sampling, percutaneous umbilical cord sampling or in vitro fertilization embryos or products of conception, but are preferably from maternal peripheral blood. Fetal cells may be enriched by density gradient centrifugation. Fetal cells may also be enriched by removing maternal cells with an antibody to a cell surface antigen, e.g. anti-CD45, either immobilized or by fluorescence-activated cell sorting. Fetal cells are also distinguishable from maternal cells by staining, e.g. with a labeled antibody to cytokeratin or to fetal hemoglobin, or for fetal hemoglobin by hematoxylin/eosin, or by in situ hybridization to detect one or more fetal mRNAs, e.g., of fetal hemoglobin or fetoprotein. Amplification may be used in conjunction with the in situ hybridization. Fetal cells circulating in maternal blood may be separated by flow cytometry, sorting on their intrinsic light scattering properties. Fetal nucleated erythrocytes may be identified by a label for fetal hemoglobin. Fetal cells may be treated to determine genetic characteristics or abnormalities, infectious agents or other properties by nucleic acid hybridization. Genetic abnormalities may include deletions, additions, amplifications, translocations or rearrangements. Multiple abnormalities may also be detected simultaneously, and they may be visually distinguished by color. Kits are provided for the disclosed procedures.
REFERENCES:
patent: 5506105 (1996-04-01), Haydock
Haydock et al. Journal Cell Biology (1990), vol. III, No. 5, pt 2, p. 57a, Abstract 298.
Asgari Morteza
Blick Mark
Bresser Joel
Cubbage Michael Lee
Prashad Nagindra
Aprogenex, Inc.
Myers Carla J.
LandOfFree
Amplification of mRNA for distinguishing fetal cells in maternal does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Amplification of mRNA for distinguishing fetal cells in maternal, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amplification of mRNA for distinguishing fetal cells in maternal will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1513918